Cargando…
Sentinel Node Biopsy in Ductal Carcinoma in Situ: Is it Justifiable?
Background: For invasive breast cancer, sentinel node biopsy (SNB) is an acceptable alternative to axillary node clearance (ANC), although in the recent era, its role is under review. In ductal carcinoma in situ (DCIS), the benefit of SNB is even less well defined. Despite this, guidelines still rec...
Autores principales: | Al-Shurbasi, Nour, Hirst, Natalie A, Kohlhardt, Stanley |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7928077/ https://www.ncbi.nlm.nih.gov/pubmed/33680604 http://dx.doi.org/10.7759/cureus.13062 |
Ejemplares similares
-
De-escalation of Sentinel Lymph Node Biopsy in Patients With Ductal Carcinoma In Situ
por: Abdulla, Hussain A, et al.
Publicado: (2023) -
Ductal Carcinoma In Situ and Sentinel Lymph Node Biopsy
por: Son, Bok Kyoung, et al.
Publicado: (2011) -
Sentinel lymph node biopsy with one-step nucleic acid assay relegates the need for preoperative ultrasound-guided biopsy staging of the axilla in patients with early stage breast cancer
por: Inua, Bello, et al.
Publicado: (2021) -
Long-Term Outcomes of Sentinel Lymph Node Biopsy for Ductal Carcinoma in Situ
por: Hung, Peiyin, et al.
Publicado: (2019) -
Surgeons’ preferences for using sentinel lymph node biopsy in patients with ductal carcinoma in situ
por: Meurs, Claudia J. C., et al.
Publicado: (2022)